Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Genetown entities : Gilead sciences, inc. save search
Gilead Sciences Publishes 2023 ESG Impact Report
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
GILD | $66.69 -0.58% 850K
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
gilead report sciences impact esg
Gilead Sciences CEO on Company's Evolution and Commitment to the Bay Area
Published: 2024-03-05 (Crawled : 14:30) - biospace.com/
GILD | $66.69 -0.58% 850K
|
Health Technology
|
| O: 0.21%
H: 0.84%
C: 0.81%
ceo bay sciences
Gilead Sets Sights on Hepatitis C Elimination As It Marks 10 Years of Curative Therapies
Published: 2024-02-13 (Crawled : 14:00) - biospace.com/
GILD | $66.69 -0.58% 850K
|
Health Technology
|
| O: 0.32%
H: 0.11%
C: -1.55%
hepatitis
Lyndra Therapeutics Announces Leadership Changes, Update on Pivotal Trial Progress
Published: 2023-07-17 (Crawled : 13:20) - biospace.com/
FNCTF | News | $11.16 1.13% 0
|
Communications
|
| O: 4.62%
H: 0.0%
C: -1.54%
GILD | $66.69 -0.58% 850K
|
Health Technology
|
| O: -0.67%
H: 1.42%
C: 1.06%
update trial therapeutics
Lyndra Therapeutics Doses First Clinical Trial Participant in Pivotal Study of Oral Weekly Risperidone (LYN-005) for Schizophrenia and Schizoaffective Disorder
Published: 2023-05-09 (Crawled : 15:00) - biospace.com/
FNCTF | News | $11.16 1.13% 0
|
Communications
|
| O: -0.66%
H: 0.0%
C: 0.0%
GILD | $66.69 -0.58% 850K
|
Health Technology
|
| O: -0.36%
H: 1.23%
C: 0.63%
lyn-005 schizophrenia trial therapeutics study
Lyndra Therapeutics’ LYNX™ Drug Delivery Platform Wins 2022 Fierce Life Sciences Innovation Award for Drug Delivery Technology
Published: 2022-11-15 (Crawled : 21:00) - biospace.com/
GILD | $66.69 -0.58% 850K
|
Health Technology
|
| O: 0.34%
H: 0.61%
C: -0.16%
award sciences drug life technology innovation platform
Jounce Therapeutics Reports Results from Phase 2 Randomized SELECT Trial Testing 2 Different Doses of Vopratelimab in TISvopra Biomarker-Selected Patients
Published: 2022-08-30 (Crawled : 13:00) - biospace.com/
JNCE | $1.88 -2.59% -1.85% 0
|
Health Technology
|
| O: -20.58%
H: 0.0%
C: 0.0%
GILD | $66.69 -0.58% 850K
|
Health Technology
|
| O: 0.1%
H: 0.29%
C: -0.02%
trial therapeutics results phase 2
Jounce Therapeutics to Announce Second Quarter 2022 Financial Results and Host Conference Call on Thursday, August 4, 2022
Published: 2022-07-28 (Crawled : 13:20) - biospace.com/
JNCE | $1.88 -2.59% -1.85% 0
|
Health Technology
|
| O: 1.58%
H: 1.25%
C: -0.93%
GILD | $66.69 -0.58% 850K
|
Health Technology
|
| O: 0.16%
H: 0.17%
C: -0.98%
conference therapeutics results
AlloVir Announces $126.6 Million Registered Direct Offering
Published: 2022-07-27 (Crawled : 12:00) - biospace.com/
GILD | $66.69 -0.58% 850K
|
Health Technology
|
| O: -0.4%
H: 1.63%
C: 0.86%
ALVR | $0.77 -1.28% 17K
|
Health Technology
|
| O: 4.99%
H: 30.79%
C: 6.61%
offering
Jounce Therapeutics to Announce First Quarter 2022 Financial Results and Host Conference Call on Thursday, May 5, 2022
Published: 2022-04-28 (Crawled : 20:00) - biospace.com/
JNCE | $1.88 -2.59% -1.85% 0
|
Health Technology
|
| O: 0.66%
H: 0.49%
C: -6.05%
GILD | $66.69 -0.58% 850K
|
Health Technology
|
| O: -0.81%
H: 0.0%
C: 0.0%
conference therapeutics results
Jounce Therapeutics to Participate in Raymond James LILRB/ILT Symposium: Deep Dive into “Myeloid Checkpoint” Therapeutics in Cancer
Published: 2022-04-20 (Crawled : 13:00) - biospace.com/
JNCE | $1.88 -2.59% -1.85% 0
|
Health Technology
|
| O: 1.85%
H: 4.2%
C: 2.17%
GILD | $66.69 -0.58% 850K
|
Health Technology
|
| O: 2.4%
H: 0.0%
C: 0.0%
therapeutics cancer
AlloVir Appoints Diana M. Brainard, M.D., as Chief Executive Officer, Effective May 17, 2021
Published: 2021-03-22 (Crawled : 21:00) - biospace.com/
GILD | $66.69 -0.58% 850K
|
Health Technology
|
| O: -0.63%
H: 2.51%
C: 2.3%
ALVR | $0.77 -1.28% 17K
|
Health Technology
|
| O: 1.14%
H: 3.15%
C: -0.27%
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
CSSE 4 | $0.299 96.32% 7M
|
Consumer Services
BRFH 4 | $1.99 80.91% 13M
|
Manufacturing
LICN | $1.0 78.57% 3.3M
|
BOF | $1.915 63.68% 620K
|
MTC | $3.62 61.61% 790K
|
Technology Services
AMST | $3.13 56.5% 500K
|
Technology Services
ACON | $0.3595 24.83% 3.5M
|
n/a
ILAG | $0.669 23.89% 13M
|
CDTX | News | $14.57 18.55% 330K
|
Health Technology
MNY | $2.11 17.22% 180K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.